Jonathan Wosen

By Angus Chen and Jonathan Wosen Feb. 8, 2024 T hree years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made

By Angus Chen and Jonathan Wosen Feb. 12, 2024 T here was a time when an allegation of data mishandling, scientific misconduct, or just a

By Jonathan Wosen April 7, 2024 S AN DIEGO — For decades, the Food and Drug Administration's accelerated approval pathway has helped companies

By Jonathan Wosen April 7, 2024 S AN DIEGO — Cancer cases among younger people have been rising for years, a trend researchers have struggled to explain.

By Jonathan Wosen April 10, 2024 S AN DIEGO — Kimryn Rathmell, director of the National Cancer Institute, gestured toward the screen and

The authors argue that the APOE4 gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

New ways of identifying and testing therapies, a more precise understanding of disease, and a renewed sense of urgency could help speed up drug development.

By Jonathan Wosen May 14, 2024 S AN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag

Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.

The studies, conducted in mice and monkeys, showed that researchers could begin to shepherd immune cells toward producing antibodies that block a broad swath of viral strains — an important first step.